Semin Thromb Hemost 1995; 21(S 02): 59-65
DOI: 10.1055/s-0032-1313604
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Preoperative Evaluation of Primary Hemostasis in Patients with Thrombocytopenia Using the Thrombostat 4000

Anna Edsfors Åleskog
,
Andreas Killander
,
Karin Olsson
,
Lars Eriksson
,
J örgen Kristensen
Further Information

Publication History

Publication Date:
09 May 2012 (online)

Abstract

It is difficult to estimate the risk of hemorrhage that may follow an invasive or surgical procedure in patients with thrombocytopenia or platelet dysfunction. Conventional functional tests for the evaluation of primary hemostasis have been questioned. We have evaluated the in vitro bleeding time (IVBT) using the Thrombostat 4000 in 25 patients with thrombocytopenia in order to estimate the risk of bleeding following an invasive or surgical procedure. Using the IVBT, it was possible to suggest and evaluate preoperative treatment in order to restore primary hemostasis. All patients studied had their operations without bleeding complications. From these observations we conclude that the IVBT is a convenient and useful tool in the evaluation of primary hemostasis in these patients.

 
  • References

  • 1 Ivy AC, Shaprio PF, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstet 60: 781 1935;
  • 2 Lind SE. The bleeding time does not predict surgical bleeding. Blood 77: 2547-2552 1991;
  • 3 Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 16: 1-20 1990;
  • 4 De Caterina R, Lanza M, Manca G, Strata GB, Maffei S, Salvatore L. Bleeding time and bleeding: An analysis of the relationship of bleeding time test with parameters of surgical bleeding. Blood 10: 3363-3370 1994;
  • 5 Kratzer MAA, Born GVR. Simulation of primary haemostasis in vitro. Haemostasis 15: 357-362 1985;
  • 6 Kratzer MAA, Bellucci S, Caen JP. Detection of abnormal platelet functions with an in vitro model of primary haemostasis. Haemostasis 15: 363-370 1985;
  • 7 Kretschmer V, Huss B, Dietrich G, Heymanns J, Pflüger K-H. Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution. Transfus Sci 14: 27-34 1993;
  • 8 Kristensen J, Eriksson L, Olsson K, Killander A. Högman CF: Functional capacity of transfused platelets estimated by the Thrombostat 4000/2. Eur J Haematol 57: 152-155 1993;
  • 9 Eriksson L, Kristensen J, Olsson K, Högman CF. Evaluation of the functional capacity and corrected count increment of transfused platelets: Comparison between platelet concentrates derived from pooled buffy coats and apheresis. Vox Sang (submitted)
  • 10 Colton T. Statistical inference: Inference on means. In: Colton T, (Ed) Statistics in Medicine . Little. Brown; Boston: 1974: 151-189
  • 11 Kretschmer V, Schikor B, Söhngen D, Dietrich G. In vitro bleeding test- a simple method for detection of aspirin effects on platelet function. Thromb Res 56: 593-602 1989;
  • 12 Beutler E. Platelet transfusions: The 20.000/μ1 trigger. Blood 6: 1411-1413 1993;
  • 13 Harker LA, Slichter SH. The bleeding time as a screening test for evaluation of platelet dysfunction. N Engl J Med 287: 155-158 1972;